FGFR1 and gastric cancer: miR-497 targeted to inhibition of FGFR1 expression blocked gastric cancer cells proliferation and induced apoptosis, indicating that miR-497 and FGFR1 may serve as a potential therapeutic target for the treatment of gastric cancer.